NYSE:HQH

Tekla Healthcare Investors Stock Forecast, Price & News

$26.75
+0.21 (+0.79 %)
(As of 09/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$26.40
$26.75
50-Day Range
$25.11
$27.93
52-Week Range
$19.43
$28.05
Volume74,572 shs
Average Volume139,454 shs
Market Capitalization$1.19 billion
P/E RatioN/A
Dividend Yield7.57%
Beta0.99
30 days | 90 days | 365 days | Advanced Chart
Receive HQH News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Healthcare Investors and its competitors with MarketBeat's FREE daily newsletter.


Tekla Healthcare Investors logo

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.21 out of 5 stars

Finance Sector

1124th out of 1,329 stocks

Investment Offices, Not Elsewhere Classified Industry

78th out of 156 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions

What stocks does MarketBeat like better than Tekla Healthcare Investors?

Wall Street analysts have given Tekla Healthcare Investors a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tekla Healthcare Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tekla Healthcare Investors?

Tekla Healthcare Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 161,300 shares, an increase of 165.7% from the August 15th total of 60,700 shares. Based on an average daily volume of 120,700 shares, the short-interest ratio is currently 1.3 days.
View Tekla Healthcare Investors' Short Interest
.

How has Tekla Healthcare Investors' stock been impacted by Coronavirus?

Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HQH stock has increased by 49.7% and is now trading at $26.75.
View which stocks have been most impacted by COVID-19
.

How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?

Tekla Healthcare Investors declared a quarterly dividend on Wednesday, August 18th. Stockholders of record on Friday, August 27th will be given a dividend of $0.52 per share on Thursday, September 30th. This represents a $2.08 dividend on an annualized basis and a yield of 7.78%. The ex-dividend date is Thursday, August 26th. This is a positive change from Tekla Healthcare Investors's previous quarterly dividend of $0.50.
View Tekla Healthcare Investors' dividend history
.

Is Tekla Healthcare Investors a good dividend stock?

Tekla Healthcare Investors pays an annual dividend of $2.01 per share and currently has a dividend yield of 7.57%. HQH has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Tekla Healthcare Investors' dividend history.

Who are Tekla Healthcare Investors' key executives?

Tekla Healthcare Investors' management team includes the following people:
  • Dan Omstead, President & Trustee
  • Laura F. Woodward, Secretary, Treasurer & Chief Compliance Officer

Who are some of Tekla Healthcare Investors' key competitors?

What other stocks do shareholders of Tekla Healthcare Investors own?

What is Tekla Healthcare Investors' stock symbol?

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

Who are Tekla Healthcare Investors' major shareholders?

Tekla Healthcare Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (6.89%), Morgan Stanley (6.89%), Royal Bank of Canada (1.24%), Wells Fargo & Company MN (0.89%), Lazard Asset Management LLC (0.75%) and LPL Financial LLC (0.66%).
View institutional ownership trends for Tekla Healthcare Investors
.

Which institutional investors are selling Tekla Healthcare Investors stock?

HQH stock was sold by a variety of institutional investors in the last quarter, including Punch & Associates Investment Management Inc., 1832 Asset Management L.P., 1832 Asset Management L.P., Lazard Asset Management LLC, City of London Investment Management Co. Ltd., Matisse Capital, Bank of America Corp DE, and Claraphi Advisory Network LLC.
View insider buying and selling activity for Tekla Healthcare Investors
or view top insider-selling stocks.

Which institutional investors are buying Tekla Healthcare Investors stock?

HQH stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Royal Bank of Canada, Private Advisor Group LLC, LPL Financial LLC, B. Riley Wealth Management Inc., First Trust Advisors LP, and Advisor Group Holdings Inc..
View insider buying and selling activity for Tekla Healthcare Investors
or or view top insider-buying stocks.

How do I buy shares of Tekla Healthcare Investors?

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Healthcare Investors' stock price today?

One share of HQH stock can currently be purchased for approximately $26.75.

How much money does Tekla Healthcare Investors make?

Tekla Healthcare Investors has a market capitalization of $1.19 billion.

How many employees does Tekla Healthcare Investors have?

Tekla Healthcare Investors employs 147,000 workers across the globe.

What is Tekla Healthcare Investors' official website?

The official website for Tekla Healthcare Investors is www.teklacap.com.

Where are Tekla Healthcare Investors' headquarters?

Tekla Healthcare Investors is headquartered at 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109.

How can I contact Tekla Healthcare Investors?

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at (617) 772-8500 or via email at [email protected]


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.